Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7375213 Methods of producing C-aryl glucoside SGLT2 inhibitors

Patent 7375213 was granted and assigned to Bristol-Myers Squibb on May, 2008 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 16 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 16 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12115179 Pharmaceutical composition, methods for treating and uses thereof
0
Edits on 12 Mar, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Mar, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11918596 Pharmaceutical composition, methods for treating and uses thereof
0
Edits on 7 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11833166 Pharmaceutical composition, methods for treating and uses thereof
0
Edits on 1 Sep, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 1 Sep, 2023
Edits made to:
Article (+244 characters)
Article

Patent abstract

Method for the production of C-aryl glucoside SGLT2 inhibitors useful for the treatment of diabetes and related diseases. and intermediates thereof. The C-aryl glucosides may be complexed with amino acid complex forming reagents.

Edits on 7 Jun, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Jun, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11666590 Pharmaceutical composition, methods for treating and uses thereof
0
Edits on 31 May, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 31 May, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11660308 Pharmaceutical composition comprising dapagliflozin
0
Edits on 22 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 22 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=0737521300
Edits on 20 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 20 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 07375213 Methods of producing C-aryl glucoside SGLT2 inhibitors US Patent 7375213 Methods of producing C-aryl glucoside SGLT2 inhibitors

Infobox
Patent Number
0737521300
Patent Number
737521300
Edits on 28 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 28 Apr, 2023
Infobox
Is a
Patent
Patent
0
Current Assignee
Bristol-Myers Squibb
Bristol-Myers Squibb
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
073752130
Date of Patent
May 20, 2008
0
Patent Application Number
107450750
Date Filed
December 23, 2003
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=073752130
Patent Primary Examiner
‌
Shaojia Anna Jiang
0
Edits on 26 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Infobox
Is a
Patent
Patent
0
Current Assignee
Bristol-Myers Squibb
Bristol-Myers Squibb
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
073752130
Date of Patent
May 20, 2008
0
Patent Application Number
107450750
Date Filed
December 23, 2003
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=073752130
Patent Primary Examiner
‌
Shaojia Anna Jiang
0
Edits on 17 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 17 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=07375213
Edits on 29 Nov, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 29 Nov, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 07375213 Methods of producing C-aryl glucoside SGLT2 inhibitors

Infobox
Is a
Patent
Patent
Current assignee
Bristol-Myers Squibb
Bristol-Myers Squibb
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
07375213
Date of patent
May 20, 2008
Patent application number
10745075
Date Filed
December 23, 2003
Patent primary examiner
‌
Shaojia Anna Jiang

Find more entities like US Patent 7375213 Methods of producing C-aryl glucoside SGLT2 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.